Melanoma Institute Australia (MIA)

Sydney, New South Wales 2060

0 studies enrolling now · 1 studies all time

What they study most

Malignant Melanoma Stage III

Studies at this site

• Neoadjuvant Ipilimumab Plus Nivolumab Versus Standard Adjuvant Nivolumab in Macroscopic Stage III Melanoma — Running, not enrolling